ALKERMES | Dochód Netto



Net Income Zmiana Data
AbbVie USD 1.29B 1.31B 2025-03
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
ALKERMES USD 22.46M 344.61M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
J&J USD 11B 7.57B 2025-03
Malin Corporation EUR 0 1.1M 2024-06
Merck USD 5.08B 1.34B 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Otsuka Holdings JPY 85B 66.45B 2025-03
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



ALKERMES Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.